BioCentury | Apr 1, 2019
Company News

Management tracks: AACR, Acadia, Aerie

...Smith was senior medical director, global clinical development at Eli Lilly and Co. (NYSE:LLY). The Global Health Innovative Technology (GHIT) Fund...
...and unit head of Japan commercial operations and customer experience at Bristol-Myers Squibb Co. (NYSE:BMY). GHIT...
...of development partnerships aimed at neglected diseases. BioCentury Staff AACR Acadia Pharmaceuticals Inc. Aerie Pharmaceuticals Inc. Artios Pharma Ltd. Audentes Therapeutics Inc. Global Health Innovative Technology (GHIT) Fund Surface...
BioCentury | Jan 23, 2019
Translation in Brief

Partners in Neglected Infections

...in part with $1.1 million awarded in 2014 by Japan's Global Health Innovative Technology Fund (GHIT...
BioCentury | Jan 17, 2019
Finance

Public funding highlights

...would update the Strategic Plan for Data Science, announced in 2018. Strategy Dec. 13 Global Health Innovative Technology (GHIT) Fund GHIT...
...three new translational partnerships in malaria, tuberculosis, dengue fever and leishmaniasis. Separately, on Oct. 15, GHIT...
BioCentury | Jun 7, 2018
Company News

Management tracks: Alder, BIO

...Medicine Inc. (NASDAQ:EDIT) and Levin is chairman and CEO of Ovid Therapeutics Inc. (NASDAQ:OVID). The Global Health Innovative Technology (GHIT) Fund...
...He is succeeded by Hiroki Nakatani, who was assistant director-general of the World Health Organization. GHIT...
BioCentury | Apr 5, 2018
Finance

Public funding highlights

...diagnose, treat and prevent mental health conditions Grants March 28 Global Health Innovative Technology (GHIT) Fund Global Health Innovative Technology (GHIT...
BioCentury | Feb 22, 2018
Finance

Bigger BRAIN Initiative

...higher relative citation ratios for published work than typical R01 grantees. Strategy Oct. 31 Global Health Innovative Technology (GHIT) Fund GHIT...
BioCentury | Feb 8, 2018
Finance

External rethink

...PPPs since 2014. Japan led the way with 23 partnerships, including 4 backed by the Global Health Innovative Technology (GHIT) Fund...
...interest in infectious disease deals remained higher than neurology ones, bolstered in part by four GHIT...
...Xetra:EVT), Hamburg, Germany Genentech Inc., South San Francisco, Calif. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Global Health Innovative Technology (GHIT) Fund...
BioCentury | Dec 1, 2017
Company News

Astellas, MMV partner to identify antimalarial compounds

...Pharma Inc. (Tokyo:4503), Tokyo, Japan Medicines for Malaria Venture, Geneva, Switzerland Business: Infectious Allison Johnson Astellas Pharma Inc. Global Health Innovative Technology (GHIT) Fund Griffith...
BioCentury | Oct 27, 2017
Company News

Astellas partners with TB Alliance to develop new TB drugs

...Innovative Technology Fund (GHIT Fund) will provide undisclosed funding for the collaboration. Launched in 2013, GHIT...
...R&D in diseases including TB, malaria, and tropical parasites. Astellas has provided funding for the GHIT...
BioCentury | Jul 20, 2017
Finance

Sharpless edge for NCI

...goal here is to get products out the door.” BT Slingsby, Global Health Innovative Technology (GHIT) Fund GHIT growth The Global Health Innovative Technology (GHIT) Fund...
...that it had secured $200 million for its planned second five-year phase, beginning in 2018. GHIT...
...by GHIT grants includes one Japanese partner and one partner from outside Japan. BT Slingsby, GHIT’s...
Items per page:
1 - 10 of 37
BioCentury | Apr 1, 2019
Company News

Management tracks: AACR, Acadia, Aerie

...Smith was senior medical director, global clinical development at Eli Lilly and Co. (NYSE:LLY). The Global Health Innovative Technology (GHIT) Fund...
...and unit head of Japan commercial operations and customer experience at Bristol-Myers Squibb Co. (NYSE:BMY). GHIT...
...of development partnerships aimed at neglected diseases. BioCentury Staff AACR Acadia Pharmaceuticals Inc. Aerie Pharmaceuticals Inc. Artios Pharma Ltd. Audentes Therapeutics Inc. Global Health Innovative Technology (GHIT) Fund Surface...
BioCentury | Jan 23, 2019
Translation in Brief

Partners in Neglected Infections

...in part with $1.1 million awarded in 2014 by Japan's Global Health Innovative Technology Fund (GHIT...
BioCentury | Jan 17, 2019
Finance

Public funding highlights

...would update the Strategic Plan for Data Science, announced in 2018. Strategy Dec. 13 Global Health Innovative Technology (GHIT) Fund GHIT...
...three new translational partnerships in malaria, tuberculosis, dengue fever and leishmaniasis. Separately, on Oct. 15, GHIT...
BioCentury | Jun 7, 2018
Company News

Management tracks: Alder, BIO

...Medicine Inc. (NASDAQ:EDIT) and Levin is chairman and CEO of Ovid Therapeutics Inc. (NASDAQ:OVID). The Global Health Innovative Technology (GHIT) Fund...
...He is succeeded by Hiroki Nakatani, who was assistant director-general of the World Health Organization. GHIT...
BioCentury | Apr 5, 2018
Finance

Public funding highlights

...diagnose, treat and prevent mental health conditions Grants March 28 Global Health Innovative Technology (GHIT) Fund Global Health Innovative Technology (GHIT...
BioCentury | Feb 22, 2018
Finance

Bigger BRAIN Initiative

...higher relative citation ratios for published work than typical R01 grantees. Strategy Oct. 31 Global Health Innovative Technology (GHIT) Fund GHIT...
BioCentury | Feb 8, 2018
Finance

External rethink

...PPPs since 2014. Japan led the way with 23 partnerships, including 4 backed by the Global Health Innovative Technology (GHIT) Fund...
...interest in infectious disease deals remained higher than neurology ones, bolstered in part by four GHIT...
...Xetra:EVT), Hamburg, Germany Genentech Inc., South San Francisco, Calif. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Global Health Innovative Technology (GHIT) Fund...
BioCentury | Dec 1, 2017
Company News

Astellas, MMV partner to identify antimalarial compounds

...Pharma Inc. (Tokyo:4503), Tokyo, Japan Medicines for Malaria Venture, Geneva, Switzerland Business: Infectious Allison Johnson Astellas Pharma Inc. Global Health Innovative Technology (GHIT) Fund Griffith...
BioCentury | Oct 27, 2017
Company News

Astellas partners with TB Alliance to develop new TB drugs

...Innovative Technology Fund (GHIT Fund) will provide undisclosed funding for the collaboration. Launched in 2013, GHIT...
...R&D in diseases including TB, malaria, and tropical parasites. Astellas has provided funding for the GHIT...
BioCentury | Jul 20, 2017
Finance

Sharpless edge for NCI

...goal here is to get products out the door.” BT Slingsby, Global Health Innovative Technology (GHIT) Fund GHIT growth The Global Health Innovative Technology (GHIT) Fund...
...that it had secured $200 million for its planned second five-year phase, beginning in 2018. GHIT...
...by GHIT grants includes one Japanese partner and one partner from outside Japan. BT Slingsby, GHIT’s...
Items per page:
1 - 10 of 37